Target intelligence / Profile preview

Disaccharidase

Molecular classification
Enzyme, Hydrolase, Glycoside hydrolase
01

Overview

Disaccharidases are a group of essential hydrolase enzymes located on the brush border membrane of the small intestinal enterocytes [UniProt, https://www.uniprot.org/uniprotkb/P14410/entry]. They catalyze the final step of carbohydrate digestion by breaking down disaccharides, such as sucrose, maltose, and lactose, into monosaccharides like glucose and fructose for systemic absorption [NIH, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945292/]. Key enzymes in this class include sucrase-isomaltase, maltase-glucoamylase, and lactase. In therapeutic contexts, these enzymes are the primary targets for alpha-glucosidase inhibitors like acarbose and miglitol, which are used to manage postprandial hyperglycemia in type 2 diabetes mellitus [StatPearls, https://www.ncbi.nlm.nih.gov/books/NBK557848/]. By inhibiting these enzymes, the rate of glucose entry into the bloodstream is reduced, helping to stabilize blood sugar levels. Conversely, deficiencies in these enzymes lead to clinical malabsorption syndromes characterized by osmotic diarrhea and bloating due to the fermentation of undigested sugars by colonic bacteria [PubChem, https://pubchem.ncbi.nlm.nih.gov/compound/Acarbose].

Other names
Intestinal disaccharidasesBrush border enzymesAlpha-glucosidasesGlycoside hydrolases
02

Mechanism of action

Competitive inhibition of intestinal alpha-glucosidases and disaccharidases, which delays the hydrolysis of dietary oligosaccharides and disaccharides into monosaccharides, thereby slowing glucose absorption.

03

Biological functions

Carbohydrate digestionHydrolysis of glycosidic bondsNutrient absorption
04

Disease associations

Type 2 diabetes mellitusLactose intoleranceCongenital sucrase-isomaltase deficiencyMalabsorption syndrome
05

Safety considerations

Gastrointestinal side effects (flatulence, diarrhea, abdominal pain)Malabsorption of essential nutrientsContraindicated in inflammatory bowel disease or intestinal obstruction
06

Interacting drugs

Acarbose

2 more in the full profile.

07

Biomarkers

Postprandial blood glucose levelsHbA1cHydrogen breath testDisaccharidase activity assay (intestinal biopsy)

Beyond the preview

Go deeper on Disaccharidase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Disaccharidase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call